Teva Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals

TEVA 20.03

-1.1%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

RonBerk

To: RonBerk who wrote (333)	11/5/2022 8:15:24 PM
From: Lance Bredvold	1 Recommendation of 340

I was just reading a review of the drug companies which are showing excellent price rises this year including JNJ which I own some of. The article pointed out that JNJ plus 3 of the big drug distributors settled a major opioid class action in February as a group. I believe they built a good sized fund which many of the states agreed to split up among themselves. So why weren't TEVA and Perdue involved? I don't have an answer. Maybe more directly responsible as Perdue certainly seems to have been. At any rate I have no feel for how many more cases and class actions TEVA faces. As usual, the price declined rapidly again after the brief surge with a settlement. I sold a few at $9 for the tax loss. But there are many more. And, of course we still suffer from the loss of exclusivity on the huge MS drug (whose name I hoped would come to me before now). Copaxone? I was busy cheering for Tysabri from Elan (later BIIB) and hoping TEVA's offering would fall off a cliff at the time.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next